Provided by Tiger Fintech (Singapore) Pte. Ltd.

Neurocrine Biosciences

132.02
-2.0900-1.56%
Post-market: 132.020.00000.00%17:19 EDT
Volume:757.99K
Turnover:100.35M
Market Cap:13.07B
PE:44.64
High:134.94
Open:134.94
Low:131.12
Close:134.11
Loading ...
Dec 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 01, 2024

Major Issues Report

Form 8-K - Current report
Oct 30, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 30, 2024

Major Issues Report

Form 8-K - Current report
Oct 17, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Oct 11, 2024

Major Issues Report

Form 8-K - Current report
Sep 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 28, 2024

Major Issues Report

Form 8-K - Current report
Aug 01, 2024

Major Issues Report

Form 8-K - Current report
Aug 01, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 01, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 30, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities